Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin | Zendy

Seow Theng Ong | Zendy; Saumya Bajaj | Zendy; Mark R. Tanner | Zendy; Shih Chieh Chang | Zendy; Bankala Krishnarjuna | Zendy; Xuan Rui Ng | Zendy; Rodrigo A. V. Morales | Zendy; Ming Wei Chen | Zendy; Dahai Luo | Zendy; Dharmeshkumar Patel | Zendy; Sabina Yasmin | Zendy; Jeremy Jun Heng Ng | Zendy; Zhong Zhuang | Zendy; Hai M. Nguyen | Zendy; Abbas El Sahili | Zendy; Julien Lescar | Zendy; Rahul Patil | Zendy; Susan A. Charman | Zendy; Edward G. Robins | Zendy; Julian Goggi | Zendy; Peng Wen Tan | Zendy; Pragalath Sadasivam | Zendy; Boominathan Ramasamy | Zendy; Siddana V. Hartimath | Zendy; Vikas Dhawan | Zendy; Janna Bednenko | Zendy; Paul A. Colussi | Zendy; Heike Wulff | Zendy; Michael W. Pennington | Zendy; Serdar Kuyucak | Zendy; Raymond S. Norton | Zendy; Christine Beeton | Zendy; K. George Chandy | Zendy

Open Access

Modulation of Lymphocyte Potassium Channel K_V1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin

Author(s) -

Seow Theng Ong,

Saumya Bajaj,

Mark R. Tanner,

Shih Chieh Chang,

Bankala Krishnarjuna,

Xuan Rui Ng,

Rodrigo A. V. Morales,

Ming Wei Chen,

Dahai Luo,

Dharmeshkumar Patel,

Sabina Yasmin,

Jeremy Jun Heng Ng,

Zhong Zhuang,

Hai M. Nguyen,

Abbas El Sahili,

Julien Lescar,

Rahul Patil,

Susan A. Charman,

Edward G. Robins,

Julian Goggi,

Peng Wen Tan,

Pragalath Sadasivam,

Boominathan Ramasamy,

Siddana V. Hartimath,

Vikas Dhawan,

Janna Bednenko,

Paul A. Colussi,

Heike Wulff,

Michael W. Pennington,

Serdar Kuyucak,

Raymond S. Norton,

Christine Beeton,

K. George Chandy

Publication year - 2020

Publication title -

acs pharmacology and translational science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.271

H-Index - 10

ISSN - 2575-9108

DOI - 10.1021/acsptsci.0c00035

Subject(s) - potassium channel , effector , arthritis , chemistry , microbiology and biotechnology , receptor , in vivo , autoimmune disease , peptide , ion channel , transgene , antigen , autoimmunity , immunology , biology , biophysics , immune system , biochemistry , antibody , gene

We describe a cysteine-rich, membrane-penetrating, joint-targeting, and remarkably stable peptide, EgK5, that modulates voltage-gated K V 1.3 potassium channels in T lymphocytes by a distinctive mechanism. EgK5 enters plasma membranes and binds to K V 1.3, causing current run-down by a phosphatidylinositol 4,5-bisphosphate-dependent mechanism. EgK5 exhibits selectivity for K V 1.3 over other channels, receptors, transporters, and enzymes. EgK5 suppresses antigen-triggered proliferation of effector memory T cells, a subset enriched among pathogenic autoreactive T cells in autoimmune disease. PET-CT imaging with 18 F-labeled EgK5 shows accumulation of the peptide in large and small joints of rodents. In keeping with its arthrotropism, EgK5 treats disease in a rat model of rheumatoid arthritis. It was also effective in treating disease in a rat model of atopic dermatitis. No signs of toxicity are observed at 10-100 times the in vivo dose. EgK5 shows promise for clinical development as a therapeutic for autoimmune diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research